Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03823625
Title An Open-label, Randomized, Parallel, Non Comparative, Phase II Trial of Nivolumab Plus Ipilimumab Versus Platinum-based Chemotherapy Plus Nivolumab in Chemonaive Metastatic or Recurrent Squamous-Cell Lung Cancer (SqLC) (SQUINT)
Acronym SQUINT
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fondazione Ricerca Traslazionale
Age Groups: adult | senior
Covered Countries ITA

No variant requirements are available.